Category Archives: Campus News
Cameron’s May 15 visit to the university, part an effort by the British government to acknowledge the value and investment that U.S. biomedical research has in the UK, also included a tour of President Marc Tessier-Lavigne’s neuroscience laboratory and a meeting with Nobel Prize winning neurobiologist Paul Greengard. More »
Christian de Duve was a Nobel Prize winning cell biologist whose research centered on the separation and characterization of the organelles of living cells. de Duve and his colleagues also made significant contributions to the development of techniques and instrumentation for the study of cell biology. More »
Five years after the university committed to reducing its carbon footprint as part of Mayor Michael Bloomberg’s 2030 Carbon Challenge, Rockefeller was one of four participating universities that reached their target ahead of schedule. Bloomberg announced the results today at a press conference held in Rockefeller’s philosopher’s garden. More »
Hang, a chemist who works to develop new tools for the study of host-pathogen interactions, has discovered that many proteins involved in host immunity to viruses and bacteria are regulated by fatty acid modifications.
Rockefeller University will host a series of workshops this weekend designed to help scientists and educators prepare for the adoption of new standards for teaching science in elementary and high schools. More »
Entering an Unseen World: A Founding Laboratory and Origins of Modern Cell Biology 1910–1974 tells the story of a Rockefeller laboratory from its humble beginnings as a cancer lab, through the founding of the new science of cell biology, to the ultimate prize for scientific accomplishment. More »
The textbook, conceived and edited by Rockefeller University professor Donald W. Pfaff, is a 3,200 page, five-volume overview of both basic science and clinical issues in modern neuroscience, aimed at premedical, medical and graduate students.
Darnell will direct all aspects of the NYGC, including its scientific and research activities, and the recruitment and development of a world-class scientific team in genomic research and medicine. Founded in 2010, the NYGC will be one of the largest genomics research facilities in North America, integrating sequencing, bioinformatics and data management. More »
Nicholson Lecture brings vascular biologist to speak at Rockefeller as part of exchange program with Karolinska Institute
Christer Betsholtz will visit the Rockefeller University campus as part of a recently renewed program that supports research exchanges between the university and the Karolinska Institute. Betsholtz studies vascular biology, with a focus on cellular and molecular mechanisms for angiogenesis and vascular permeability. More »
Each doctoral candidate will be presented for the degree by his or her mentor, a tradition dating back to the university’s first commencement ceremony in 1959. Additionally, two esteemed researchers will receive honorary doctor of science degrees: James E. Darnell Jr. of Rockefeller University and Joan A. Steitz of Yale University. More »
The first Leon Levy Neuroscience Fellows Symposium will be held at Rockefeller University on Wednesday, May 16. Levy Fellows from Rockefeller, Columbia and New York universities, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College will discuss their latest neuroscience research with current Leon Levy Fellows as well as their mentors, former fellows and principal investigators involved with the fellowship program. More »
The family of the late Ralph Steinman, who died in September three days before winning the Nobel Prize, will donate much of the proceeds from the award to establish the Cohn-Steinman Professorship at Rockefeller. Combined with other donations, the professorship will create an enduring memorial to Steinman and his mentor and collaborator, Zanvil Cohn. More »
Zinder was a geneticist and microbiologist whose research on the genetics of bacteria and on the properties of bacteriophages provided important information on the mechanisms of heredity. He died February 3 after a long illness. More »
The New York Genome Center, which will become one of the largest genomic facilities in North America, will begin operations as early as spring 2012 in its 120,000 square foot Manhattan facility.
Neurobiologist visits Rockefeller as part of renewed scientific exchange program with Karolinska Institute
Thomas Perlmann, a neurobiologist at the Karolinska Institute who studies the dopamine-producing cells that die during the development of Parkinson’s disease, will visit the Rockefeller University campus this week and give the Nicholson Lecture on Friday. The lecture is part of a recently renewed program that supports research exchanges between the university and the Karolinska Institute. More »
Rockefeller University’s Center for Clinical and Translational Science (CCTS), a center aimed at accelerating the pace of translating science into real-life solutions for patients, has received $36.1 million from the National Institutes of Health to expand its work over the next five years. The CCTS is among 10 institutes nationwide to receive the renewed funding, in recognition of their successes during the first five years of the NIH’s Clinical and Translational Science Awards program. More »
Ruta, a neuroscientist interested in understanding how circuits in the brain can be modified by experience, will establish the Laboratory of Neurophysiology and Behavior this fall.
The Rockefeller University will award doctoral degrees to 23 students at its commencement ceremony today, and in addition, will award honorary doctor of science degrees to two respected scholars: Richard Axel of Columbia University and Linda B. Buck of the Fred Hutchinson Cancer Research Center. More »
Marc Tessier-Lavigne, a leading neuroscientist and the former chief scientific officer of Genentech, takes over as president of The Rockefeller University today, replacing Paul Nurse, who has left to become president of the Royal Society in London. More »
A new partnership will mimic a venture capital-funded biotechnology start-up model, whereby Pfizer funds pre-clinical and clinical development programs in return for the opportunity to potentially broaden its pipeline with novel and highly differentiated candidate drugs. More »